PATTERN OF MORTALITY AMONG DANISH THOROTRAST PATIENTS

被引:14
作者
ANDERSSON, M [1 ]
JUEL, K [1 ]
STORM, HH [1 ]
机构
[1] UNIV COPENHAGEN HOSP,RIGSHOSP,DEPT ONCOL,DK-2100 COPENHAGEN,DENMARK
关键词
THOROTRAST; THORIUM DIOXIDE; MORTALITY; COHORT;
D O I
10.1016/0895-4356(93)90037-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The mortality pattern among 999 Danish patients who had been subjected to angiography of the carotid artery with the alpha-ray emitting X-ray contrast media Thorotrast during the period 1935-47 was assessed by record linkage with the National Death Registry through 1989. Standardized mortality ratios (SMR) were calculated relative to the general population. The overall SMR was increased by 18 times during the first 3 years after Thorotrast injection. This rate reflects the often serious, underlying neurological conditions for which angiography was performed, however, mortality was increased by 3-4 fold even for the follow up period after the first 3 years. The increase in mortality was evident for all categories of cause of death, the SMR being 11.1 (95 % confidence interval (CI) 7.1-16.4) for cirrhosis of the liver, 4.7 (4.1-5.3) for cancer, 1.6 (1.3-1.9) for cardiac disease, 3.3 (2.6-4.2) for cerebrovascular diseases, 3.9 (3.3-4.5) for other natural causes, and 4.4 (3.4-5.6) for violent causes (including suicides). The SMR was generally related positively to young age at injection, to time since injection, and to the amount injected. The excess mortality can be explained only partially by underlying neurological conditions and by diseases known to be induced by Thorotrast (cirrhosis and cancer of the liver, leukaemia and other haematological diseases), and it is suggested that unspecific effects induced by the alpha-radiation of Thorotrast may have contributed.
引用
收藏
页码:637 / 644
页数:8
相关论文
共 17 条
[1]   HISTORY OF THE USE AND TOXICITY OF THOROTRAST [J].
ABBATT, JD .
ENVIRONMENTAL RESEARCH, 1979, 18 (01) :6-12
[2]  
ABE H, 1989, BIR REPORT, V21, P138
[3]   CANCER INCIDENCE AMONG DANISH THOROTRAST-EXPOSED PATIENTS [J].
ANDERSSON, M ;
STORM, HH .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (17) :1318-1325
[4]  
BRESLOW NE, 1987, IARC SCI PUBL, V82
[5]   SHARED RISK-FACTORS FOR CANCER AND ATHEROSCLEROSIS - A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE [J].
HANSEN, ES .
MUTATION RESEARCH, 1990, 239 (03) :163-179
[6]   EFFECTS OF LONG-TERM THOROTRAST EXPOSURE [J].
JANOWER, ML ;
FLYNN, MJ ;
MIETTIEN, OS .
RADIOLOGY, 1972, 103 (01) :13-&
[7]   TISSUE DOSE IN THOROTRAST PATIENTS [J].
KAUL, A ;
NOFFZ, W .
HEALTH PHYSICS, 1978, 35 (01) :113-121
[8]   EPIDEMIOLOGIC, PATHOLOGICAL AND DOSIMETRIC STATUS OF JAPANESE THOROTRAST PATIENTS [J].
MORI, T ;
KATO, Y .
JOURNAL OF RADIATION RESEARCH, 1991, 32 :34-45
[9]   TRANSFORMING GENE IN HUMAN ATHEROSCLEROTIC PLAQUE DNA [J].
PENN, A ;
GARTE, SJ ;
WARREN, L ;
NESTA, D ;
MINDICH, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (20) :7951-7955
[10]   STUDIES OF THE MORTALITY OF A-BOMB SURVIVORS .9. MORTALITY, 1950-1985 .3. NONCANCER MORTALITY BASED ON THE REVISED DOSES (DS86) [J].
SHIMIZU, Y ;
KATO, H ;
SCHULL, WJ ;
HOEL, DG .
RADIATION RESEARCH, 1992, 130 (02) :249-266